Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges

BioMed Research International

Volumn 2017, Issue , 2017, Pages

  Nii Trebi, Nicholas Israel ^a  

^a UNIVERSITY OF GHANA   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; GENETIC VARIATION; GLOBAL DISEASE BURDEN; HUMAN; INFECTION; NEGLECTED DISEASE; PUBLIC HEALTH; REVIEW; COMMUNICABLE DISEASES, EMERGING; COST OF ILLNESS; ECONOMICS; NEGLECTED DISEASES;

COMMUNICABLE DISEASES, EMERGING; COST OF ILLNESS; HUMANS; NEGLECTED DISEASES;

EID: 85014212015     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/5245021     Document Type: Review

References (111)

1. WorldHealthOrganization, "Infections and infectious diseases: A manual for nurses and midwives in the WHO European Region, " http://www. euro. who. int/ data/assets/pdf file/0013/ 102316/e79822. pdf.
2. M. Tibayrenc, Encyclopedia of Infectious Diseases: Modern Methodologies, JohnWiley & Sons, 2007.
3. A. Ashley-Koch, Q. Yang, and R. S. Olney, "Sickle hemoglobin (Hb S) allele and sickle cell disease: A HuGE review, " American Journal of Epidemiology, vol. 151, no. 9, pp. 839-845, 2000.
4. National Institutes of Health (US) and BSC Study, Understanding Emerging and Re-emerging Infectious Diseases, National Institutes of Health (US), 2007.
5. M. J. Walker, T. C. Barnett, J. D. McArthur et al., "Disease manifestations and pathogenic mechanisms of group A Streptococcus, " ClinicalMicrobiology Reviews, vol. 27, no. 2, pp. 264-301, 2014.
6. V. R. Racaniello, "Emerging infectious diseases, " The Journal of Clinical Investigation, vol. 113, no. 6, pp. 796-798, 2004.
7. N. C. Barber and L. A. Stark, "Online resources for understanding outbreaks and infectious diseases, " CBE Life Sciences Education, vol. 14, no. 1, 2015.
8. D. M. Morens, G. K. Folkers, and A. S. Fauci, "Emerging infections: A perpetual challenge, " The Lancet Infectious Diseases, vol. 8, no. 11, pp. 710-719, 2008.
9. M. Vitoria, R. Granich, C. F. Gilks et al., "The globalfight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives, " American Journal of Clinical Pathology, vol. 131, no. 6, pp. 844-848, 2009.
10. D. Rifkind andG. Freeman, TheNobel PrizeWinningDiscoveries in Infectious Diseases, Academic Press, 2005.
11. Institute of Medicine, Emerging Infections: MicrobialThreats to Health in the United States, National Academy Press, Washington, DC, USA, 1992.
12. D. M. Morens and A. S. Fauci, "Emerging infectious diseases in 2012: 20 years after the institute of medicine report, " mBio, vol. 3, no. 6, 2012.
13. J. Becker and M. Barry, Emerging and Reemerging Viral Infectious Diseases, Prepared as Part of an Education Project of the Global Health Education Consortium and Collaborating Partners, Yale University School of Medicine, New Haven, Conn, USA, 2009.
14. C. To R. The D. of D. G. E. I. S. And R. System, M. F.-U. Agency, and I. ofMedicine: "Perspectives on the Department of Defense global emerging infections surveillance and response system: A program review" National Academies Press, 2001.
15. World Health Organization, "WHO-Global infectious disease surveillance, " http://www. who. int/mediacentre/factsheets/ fs200/en/.
16. F. L. Cohen and E. Larson, "Emerging infectious diseases: nursing responses, " NursingOutlook, vol. 44, no. 4, pp. 164-168, 1996.
17. V. B. Carruthers, P. A. Cotter, and C. A. Kumamoto, "Microbial pathogenesis: mechanisms of infectious disease, " Cell Host and Microbe, vol. 2, no. 4, pp. 214-219, 2007.
18. A. Alcäs, L. Abel, and J.-L. Casanova, "Human genetics of infectious diseases: between proof of principle and paradigm, " Journal of Clinical Investigation, vol. 119, no. 9, pp. 2506-2514, 2009.
19. J. Mouchet and P. Carnevale, "Impact of changes in the environment on vector-transmitted diseases, " Sante, vol. 7, no. 4, pp. 263-269, 1997.
20. C. Neiderud, "How urbanization affects the epidemiology of emerging infectious diseases, " Infection Ecology & Epidemiology, vol. 5, 2015.
21. M. X. Tong, A. Hansen, S. Hanson-Easey et al., "Infectious diseases, urbanization and climate change: challenges in future China, " International Journal of Environmental Research and Public Health, vol. 12, no. 9, pp. 11025-11036, 2015.
22. S. S. Morse, "Factors and determinants of disease emergence, " OIE Revue Scientifique et Technique, vol. 23, no. 2, pp. 443-451, 2004.
23. J. Utzinger and J. Keiser, "Urbanization and tropical health-then and now, " Annals of Tropical Medicine and Parasitology, vol. 100, no. 5-6, pp. 517-533, 2006.
24. B. K. Defo, "Demographic, epidemiological, and health transitions: Are they relevant to population health patterns in Africa" Global Health Action, vol. 7, 2014.
25. M. Gayer, D. Legros, P. Formenty, andM. A. Connolly, "Conflict and emerging infectious diseases, " Emerging Infectious Diseases, vol. 13, no. 11, pp. 1625-1631, 2007.
26. F. R. Lashley, "Emerging infectious disease: vulnerabilities, contributing factors and approaches, " Expert Review of Anti-InfectiveTherapy, vol. 2, no. 2, pp. 299-316, 2004.
27. A. M. Marty, R. M. Conran, and M. G. Kortepeter, "Recent challenges in infectious diseases: biological pathogens as weapons and emerging endemic threats, " Clinics in Laboratory Medicine, vol. 21, no. 3, pp. 411-420, 2001.
28. Centers for Disease Control and Prevention, "Outbreaks chronology: Ebola virus disease-Ebola hemorrhagic fever-CDC, " http://www. cdc. gov/vhf/ebola/outbreaks/history/chronology. html.
29. C. Dye, "After 2015: Infectious diseases in a newera of health and development, " Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 369, no. 1645, 2014.
30. WorldHealthOrganization, "WHO/The top 10 causes of death, " http://www. who. int/mediacentre/factsheets/fs310/en/index2. html.
31. A. S. Fauci, N. A. Touchette, and G. K. Folkers, "Emerging infectious diseases: A 10-year perspective from the National Institute ofAllergy and InfectiousDiseases, "Emerging Infectious Diseases, vol. 11, no. 4, pp. 519-525, 2005.
32. Z. A. Bhutta, J. Sommerfeld, Z. S. Lassi, R. A. Salam, and J. K. Das, "Global burden, distribution, and interventions for infectious diseases of poverty, " Infectious Diseases of Poverty, vol. 3, no. 1, article 21, 2014.
33. J. N. Hays, Epidemics and Pandemics: Their Impacts on Human History, ABC-CLIO, Santa Barbara, Calif, USA, 2005.
34. "Native Americans and the smallpox epidemic-archiving early America, " http://www. varsitytutors. com/earlyamerica/earlyamerica-review/volume-11/native-americans-smallpox.
35. World Health Organization, "WHO-Smallpox, " http://www. who. int/csr/disease/smallpox/en/.
36. W. A. Orenstein, A. R. Hinman, and M. J. Papania, "Evolution of measles elimination strategies in the United States, " Journal of Infectious Diseases, vol. 189, no. 1, pp. S17-S22, 2004.
37. J. P. Baker, "The first measles vaccine, " Pediatrics, vol. 128, no. 3, pp. 435-437, 2011.
38. World Health Organization, "WHO-Measles, " http://www. who. int/mediacentre/factsheets/fs286/en/.
39. "The 1918 influenza pandemic, " https://virus. stanford. edu/uda/.
40. World Health Organization, "WHO-HIV/AIDS, " http://www. who. int/mediacentre/factsheets/fs360/en/.
41. G. D. Shanks and J. F. Brundage, "Pathogenic responses among young adults during the 1918 influenza pandemic, " Emerging Infectious Diseases, vol. 18, no. 2, pp. 201-207, 2012.
42. "MERS coronavirus: diagnostics, epidemiology and transmission/ Virology Journal/Full Text, " https://virologyj. biomedcentral. com/articles/10. 1186/s12985-015-0439-5.
43. C. J. Peters and J. W. LeDuc, "An introduction to Ebola: The virus and the disease, " Journal of Infectious Diseases, vol. 179, no. 1, pp. ix-xvi, 1999.
44. P. J. Hotez, M. Alvarado, M.-G. Basáñez et al., "The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases, " PLoS Neglected Tropical Diseases, vol. 8, no. 7, Article ID e2865, 2014.
45. M. G. Weiss, "Stigma and the social burden of neglected tropical diseases, " PLoS Neglected Tropical Diseases, vol. 2, no. 5, article e237, 2008.
46. G. C. Kombe andD. M. Darrow, "Revisiting emerging infectious diseases: The unfinished agenda, " Journal of Community Health, vol. 26, no. 2, pp. 113-122, 2001.
47. K. Deribe, K. Meribo, T. Gebre et al., "The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination, " Parasites&Vectors, vol. 5, no. 1, article no. 240, 2012.
48. J. Norris, C. Adelman, Y. Spantchak, and K. Marano, "Social and economic impact review on neglected tropical diseases, " Economic Policy/Briefing Paper, Hudson Institute, Washington, DC, USA, 2012.
49. K. B. Chua and D. J. Gubler, "Perspectives of public health laboratories in emerging infectious diseases, " Emerging Microbes and Infections, vol. 2, article no. e37, 2013.
50. J. C. Semenza, E. Lindgren, L. Balkanyi et al., "Determinants and drivers of infectious disease threat events in Europe, " Emerging Infectious Diseases, vol. 22, no. 4, pp. 581-589, 2016.
51. "Globalization and infectious diseases: A review of the linkages, " http://www. who. int/tdr/publications/documents/seb topic3. pdf.
52. A. T. Pavia, "Germs on a plane: Aircraft, international travel, and the global spread of disease, " Journal of Infectious Diseases, vol. 195, no. 5, pp. 621-622, 2007.
53. M. O. Nanyingi, P. Munyua, S. G. Kiama et al., "A systematic review of Rift Valley Fever epidemiology 1931-2014, " Infection Ecology & Epidemiology, vol. 5, Article ID28024, 2015.
54. S. S. Morse, J. A. K. Mazet, M. Woolhouse et al., "Prediction and prevention of the next pandemic zoonosis, "TheLancet, vol. 380, no. 9857, pp. 1956-1965, 2012.
55. A. Tadin, R. Tokarz, A. Markotic et al., "Molecular survey of zoonotic agents in rodents and other small mammals in Croatia, " American Journal of Tropical Medicine and Hygiene, vol. 94, no. 2, pp. 466-473, 2016.
56. B. A. Han, A. M. Kramer, and J. M. Drake, "Global patterns of zoonotic disease in mammals, " Trends in Parasitology, vol. 32, no. 7, pp. 565-577, 2016.
57. A. M. Kilpatrick and S. E. Randolph, "Drivers, dynamics, and control of emerging vector-borne zoonotic diseases, " The Lancet, vol. 380, no. 9857, pp. 1946-1955, 2012.
58. K. H. Mayer and C. Beyrer, "HIV epidemiology update and transmission factors: risks and risk contexts-16th International AIDS Conference Epidemiology Plenary, " Clinical Infectious Diseases, vol. 44, no. 7, pp. 981-987, 2007.
59. J. R. Spengler, E. D. Ervin, J. S. Towner, P. E. Rollin, and S. T. Nichol, "Perspectives on west africa ebola virus disease outbreak, 2013-2016, " Emerging Infectious Diseases, vol. 22, no. 6, p. 956, 2016.
60. World Health Organization, "Ebola Situation Report-2 March 2016/Ebola, " http://apps. who. int/ebola/current-situation/ebola-situation-report-2-march-2016.
61. World Health Organization, "WHO-Ebola virus disease, " http://www. who. int/mediacentre/factsheets/fs103/en/.
62. A. Goba, S. H. Khan, M. Fonnie et al., "An Outbreak of Ebola virus disease in the Lassa fever zone, " Journal of Infectious Diseases, vol. 214, supplement 3, pp. S110-S121, 2016.
63. H. V. Fineberg and M. E. Wilson, "Emerging infectious diseases, " IRGC Report, 2010.
64. Emerging Infectious Diseases-Beginning of the 21st Century, http://www. medscape. com/viewarticle/528306.
65. "Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens: meetingreport-prioritization. pdf, " http://www. who. int/csr/research-anddevelopment/ meeting-report-prioritization. pdf.
66. A. Merianos, "Surveillance and response to disease emergence, " Current Topics in Microbiology and Immunology, vol. 315, pp. 477-509, 2007.
67. World Health Organization, "WHO/WHO publishes list of top emerging diseases likely to causemajor epidemics, " http://www. who. int/medicines/ebola-treatment/WHO-list-of-top-emergingdiseases/ en/.
68. World Health Organization, "WHO/Zika virus, " http://www. who. int/mediacentre/factsheets/zika/en/.
69. World Health Organization, "WHO-HIV/AIDS, TB, Malaria and Neglected Tropical Diseases (HTM), " http://www. who. int/ about/structure/organigram/htm/en/.
70. K. L. Russell, J. Rubenstein, R. L. Burke et al., "Theglobal emerging infection surveillance and response system (GEIS), a U. S. government tool for improved global biosurveillance: A review of 2009, " BMC Public Health, vol. 11, supplement 2, article S2, 2011.
71. World Health Organization, "WPRO-Responding to emerging infectious disease threats, " http://www. wpro. who. int/mediacentre/ releases/2013/20131024apsed/en/.
72. C. S. Wiysonge, Z. Waggie, A. Hawkridge et al., "Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the first international African vaccinology conference, " Pan African Medical Journal, vol. 23, 2016.
73. World Health Organization, "WHO-World Health Assembly adopts resolution on neglected tropical diseases, " http://www. who. int/neglected diseases/WHA 66 seventh day resolution adopted/en/.
74. Bill and Melinda Gates Foundation, "Gates Foundation commits nearly 70 million to help fight neglected tropical diseases-Bill &Melinda Gates Foundation, " http://www. gatesfoundation. org/Media-Center/Press-Releases/2006/09/$70-Million-to-Help-Fight-Neglected-Tropical-Diseases.
75. World Health Organization, "Who-the global network for neglected tropical diseases control (GNNTDC), " http://www. who. int/neglected diseases/GNNTDC/en/.
76. Bill and Melinda Gates Foundation, "Private and public partners unite to combat 10 neglected tropical diseases by 2020, " http://www. gatesfoundation. org/media-center/press-releases/ 2012/01/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020.
77. "Control of Neglected Tropical Diseases-NEJM, " http://www. nejm. org/doi/full/10. 1056/NEJMra064142#t=article.
78. Bill and Melinda Gates Foundation, "Neglected tropical diseases, " http://www. gatesfoundation. org/What-We-Do/Global-Health/Neglected-Tropical-Diseases.
79. "London Declaration NTDs. pdf, " http://www. who. int/neglected diseases/London Declaration NTDs. pdf.
80. World Health Organization, "Accelerating work to overcome the global impact of neglected tropical diseases: A roadmap for implementation: executive summary, " 2012, http://apps. who. int/iris/handle/10665/70809.
81. Y. Zhang, C. MacArthur, L. Mubila, and S. Baker, "Control of neglected tropical diseases needs a long-term commitment, " BMC Medicine, vol. 8, article no. 67, 2010.
82. M. J. Bockarie, L. A. Kelly-Hope, M. Rebollo, and D. H. Molyneux, "Preventive chemotherapy as a strategy for elimination of neglected tropical parasitic diseases: endgame challenges, " Philosophical Transactions of the Royal Society of London. B. Biological sciences, vol. 368, no. 1623, 2013.
83. S. Kappagoda and J. P. A. Ioannidis, "Prevention and control of neglected tropical diseases: overview of randomized trials, systematic reviews and meta-analyses, " Bulletin of the World Health Organization, vol. 92, no. 5, pp. 356-366, 2014.
84. C. Hanson, A. Weaver, K. L. Zoerhoff et al., "Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: identifying best practices to roll out programs at national scale, "American Journal of Tropical Medicine and Hygiene, vol. 86, no. 3, pp. 508-513, 2012.
85. "Quantitative analysis of strategies to achieve the 2020 goals for neglected tropical diseases: where are we now" https://www. biomedcentral. com/collections/ntdmodels2015.
86. K. L. Muldrew, "Molecular diagnostics of infectious diseases, " Current Opinion in Pediatrics, vol. 21, no. 1, pp. 102-111, 2009.
87. M. Rweyemamu, D. Kambarage, E. Karimuribo et al., "Development of aOneHealthNational Capacity in Africa: The Southern African Centre for Infectious Disease Surveillance (SACIDS) OneHealth Virtual CentreModel, " Current TopicsMicrobiology Immunology, vol. 366, pp. 73-91, 2013.
88. A. M. Caliendo, D. N. Gilbert, C. C. Ginocchio et al., "Tests, better care: improved diagnostics for infectious diseases, " Clinical Infectious Diseases, vol. 57, supplement 3, pp. S139-S170, 2013.
89. World Health Organization, "WHO-7. 3 Monitoring response to ART and the diagnosis of treatment failure, " http://www. who. int/hiv/pub/guidelines/arv2013/art/artmonitoring/en/index3. html.
90. A. Calmy, N. Ford, B. Hirschel et al., "HIV viral load monitoring in resource-limited regions: optional or necessary" Clinical Infectious Diseases, vol. 44, no. 1, pp. 128-134, 2007.
91. World Health Organization, "WHO-HIV drug resistance: publications, " http://www. who. int/hiv/pub/drugresistance/en/.
92. S. Bertagnolio, C. F. Perno, S. Vella, and D. Pillay, "The impact ofHIVdrug resistance on the selection of first-and second-line ART in resource-limited settings, " Journal of Infectious Diseases, vol. 207, no. 2, pp. S45-S48, 2013.
93. B. B. C. News, "Malaria vaccine gets 'green light', " http://www. bbc. com/news/health-33641939.
94. N. D. Goswami, C. D. Pfeiffer, J. R. Horton, K. Chiswell, A. Tasneem, and E. L. Tsalik, "The state of infectious diseases clinical trials: A systematic review of clinicaltrials. gov, " PLoS ONE, vol. 8, no. 10, Article IDe77086, 2013.
95. "Maraviroc: A Coreceptor CCR5 antagonist for management of HIV infection, " http://www. medscape. com/viewarticle/ 705842 1.
96. M. Janardhanan, V. M. B. Amberkar, S. Vidyasagar, K. M. Kumari, and S. N. Holla, "Hypersensitivity reaction associated with abacavir therapy in an Indian HIV patient-a case report, " Journal of Clinical and Diagnostic Research, vol. 8, no. 9, pp. HD01-HD02, 2014.
97. World Health Organization, "WHO-about the 3 by 5 initiative, " http://www. who. int/3by5/about/initiative/en/.
98. V. D. Lima, R. Granich, P. Phillips, B. Williams, and J. S. G. Montaner, "Potential impact of the us president's emergency plan for AIDS relief on the tuberculosis/HIV coepidemic in selected sub-Saharan African countries, " Journal of Infectious Diseases, vol. 208, no. 12, pp. 2075-2084, 2013.
99. World Health Organization, "Investing to overcome the global impact of neglected tropical diseases-Third WHO report on neglected tropical diseases, " http://apps. who. int/iris/bitstream/ 10665/152781/1/9789241564861 eng. pdf?ua=1.
100. PFIZER, "The value of vaccines in disease prevention, " https:// www. pfizer. com/files/health/VOMPaper Vaccines R7. pdf.
101. ThinkProgress, "Vaccines have almost totally eliminated these 13 infectious diseases in theU. S.-thinkprogress, " https://thinkprogress. org/vaccines-have-almost-totally-eliminated-these-13-infectious-diseases-in-the-u-s-653d4a8f930e.
102. Institute of Medicine (U. S.) and Forum on Microbial Threats, Global Infectious Disease Surveillance and Detection Assessing the Challenges-Finding Solutions: Workshop Summary, National Academies Press, Washington, DC, USA, 2007.
103. World Health Organization, "WHO-Dracunculiasis (guineaworm disease), " http://www. who. int/mediacentre/factsheets/ fs359/en/.
104. S. Zyga and M. Zografakis-Sfakianakis, "Emerging and reemerging infectious diseases: A potential pandemic threat, " Health Science Journal, vol. 5, no. 3, pp. 159-168, 2011.
105. Vaccines Today, "Influenza pandemics-a brief history, " http:// www. vaccinestoday. eu/diseases/influenza-pandemics-a-briefhistory/.
106. W. G. Meyer, J. A. Pavlin, D. Hospenthal et al., "Antimicrobial resistance surveillance in the AFHSC-GEIS network, " BMC Public Health, vol. 11, no. 2, article S8, 2011.
107. E. Y. Klein, "Antimalarial drug resistance: A reviewof the biology and strategies to delay emergence and spread, " International Journal of Antimicrobial Agents, vol. 41, no. 4, pp. 311-317, 2013.
108. A. S. Fauci and D. M. Morens, "The perpetual challenge of infectious diseases, " New England Journal of Medicine, vol. 366, no. 5, pp. 454-461, 2012.
109. E. De Clercq, "Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV, " International Journal of Antimicrobial Agents, vol. 33, no. 4, pp. 307-320, 2009.
110. Institute of Medicine (U. S.) forum on microbial threats, Global Infectious Disease Surveillance and Detection: Assessing the Challenges-Finding the Solutions, National Academies Press, Washington, DC, USA, 2007.
111. J. Adams, K. A. Gurney, and D. Pendlebury, Global Research Report on Neglected Tropical Diseases, Thomson Reuters, 2012.